case_images: PMC10613082_01
case_images: Cytologic preparations of initial pleural effusion which show groups and single malignant cells with morphologic and immunophenotypic findings supportive of lung adenocarcinoma. (A) DiffQuik-stained cytospin preparation at x400, (B) Pap-stained cytospin preparation at x400, (C) hematoxylin and eosin-stained cell block preparation at x400, and (D) TTF1 immunohistochemical stain at x400.
case_images: fonc-13-1193503-g001.jpg
case_images: PMC10613082_01_fonc-13-1193503-g001.jpg
case_images: f1
case_images: The biopsy of the right upper lobe nodule revealed lung adenocarcinoma ( Figure 1 ).
case_images: Imaging following disease progression at 2 years' status post-stereotactic body radiation therapy. (A) Large left pleural effusion and left lower lobe atelectasis. (B) Abnormal fluorodeoxyglucose uptake in the upper spine; SUV of 5.5.
case_images: fonc-13-1193503-g002.jpg
case_images: PMC10613082_01_fonc-13-1193503-g002.jpg
case_images: f2
case_images: She had stable disease for 6 months but then developed worsening pleural effusion and new bone lesions ( Figures 2A, B ).
case_images: Timeline of the disease course and cfDNA trends. (A) Timeline of clinical course and treatment modalities. (B) cfDNA composition throughout the disease course.
case_images: fonc-13-1193503-g003.jpg
case_images: PMC10613082_01_fonc-13-1193503-g003.jpg
case_images: f3
case_images: At 1 month following the final cycle of fam-trastuzumab deruxtecan, the patient developed fatal acute respiratory failure secondary to pulmonary edema ( Figure 3 ).